| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128706 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/01/2004 | US20040127884 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127694 Antisense IAP oligonucleotides and uses thereof |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127684 Heat shock protein-based vaccines and immunotherapies |
| 07/01/2004 | US20040127683 Membrane protein for use in diagnosis, prevention and treatment of neurological, muscular, immunological and cell proliferative disorders; drug screening |
| 07/01/2004 | US20040127523 Methods of treating cancer with HDAC inhibitors |
| 07/01/2004 | US20040127522 histone deacetylase inhibitors administered in a safe, daily dosing regimen to have high oral bioavailability |
| 07/01/2004 | US20040127479 Peroxynitrite rearrangement catalysts |
| 07/01/2004 | US20040127477 Heterocyclic glycyl beta-alanine derivatives |
| 07/01/2004 | US20040127473 Compound |
| 07/01/2004 | US20040127451 strategy with which to derive treatments for hyperproliferative disorders, developmental disorders, inflammatory disorders, neural disorders and diseases arising from aberrant apoptosis |
| 07/01/2004 | US20040127448 introducing a DNA construct into a pancreas cell in vivo, which encodes a protein and a eukaryotic promoting sequence to be expressed and delivered into the blood stream of the mammal |
| 07/01/2004 | US20040127447 treating a vascular disease with a recombinant adenoviral vector, encoding at least one K+ channel gene operably linked to a promoter, and a pharmaceutically acceptable excipient |
| 07/01/2004 | US20040127446 Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication |
| 07/01/2004 | US20040127445 methods for screening for compounds capable of modulating the effect of B2M activity such as inhibitors, antibodies, variants or mimetics |
| 07/01/2004 | US20040127440 osteoporosis, osteopenia and Paget's disease therapy and prevention; administering a compound that lowers NPY level in blood serum |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127437 Combined therapeutical treatment of hyperproliferative diseases |
| 07/01/2004 | US20040127427 Ketoamide inhibitors in chronic nerve disease |
| 07/01/2004 | US20040127426 Peptidic compounds as cysteine protease inhibitors |
| 07/01/2004 | US20040127425 Control of nitric oxide bioactivity by perfluorocarbons |
| 07/01/2004 | US20040127423 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent |
| 07/01/2004 | US20040127422 comprising: a) an immunomodulatory peptide; and b) at least one anti-retroviral agent |
| 07/01/2004 | US20040127421 Method to increase fibronectin |
| 07/01/2004 | US20040127420 Metalloproteinase inhibitors for wound healing |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127418 derivatives of human glucagon-like peptide-2 of improved solubility and/or stability for the treatment of obesity and small bowel syndrome |
| 07/01/2004 | US20040127417 using a poly(ethylene glycol) butyraldehyde moiety; The PEGylated hGH may have an increased plasma residency duration, decreased clearance rate, improved stability, decreased antigenicity, decreased PEGylation heterogeneity or a combination thereof |
| 07/01/2004 | US20040127416 Therapeutic bioconjugates |
| 07/01/2004 | US20040127415 Stresscopins and their uses |
| 07/01/2004 | US20040127414 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes |
| 07/01/2004 | US20040127412 Modified GLP-1 peptides with increased biological potency |
| 07/01/2004 | US20040127411 either alone or in combination with standard chemotherapeutic agents |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127409 alleviating symptoms of a psychological condition such as depression, bi-polar disorders, anxiety disorders, panic attacks, agoraphobia, attention deficit syndrome, and mid-cycle dysphoria |
| 07/01/2004 | US20040127408 based on the complementarity-determining region (CDR) of a human monoclonal anti-DNA antibody |
| 07/01/2004 | US20040127407 capable of interfering with the prolactin signaling mechanism in a cancer cell; inhibits STAT-5 phosphorylation in a targeted cell; angiogenesis inhibiting domain can be endostatin, angiostatin or FLK-1-bp |
| 07/01/2004 | US20040127405 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 07/01/2004 | US20040127403 Methods for treating and preventing Gram-positive bacteremias |
| 07/01/2004 | US20040127402 Injectible composition and method for treating degenerative animal joints |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127399 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 07/01/2004 | US20040127398 Long lasting synthetic glucagon like peptide (GLP-1) |
| 07/01/2004 | US20040127396 such as rheumatoid arthritis |
| 07/01/2004 | US20040126882 Transforming cells with plasmid containing catalytic nucleotide sequences and using catalytic entity to control transcriptional expression of heterologus genes |
| 07/01/2004 | US20040126877 Fusion protein comprising gene expression inhibitory domains and activity for use in preventing lymphadenopathy associated viral infections via acting on/binding long terminal repeats; gene therapy and viricides |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126861 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/01/2004 | US20040126860 Comprises cardiac mysosin light chain kinase protein for use in identification, treatment and prevention of cardiac hypertrophy, cardiomyopathy and congestive heart failure |
| 07/01/2004 | US20040126859 Mutant forms of Fas ligand and uses thereof |
| 07/01/2004 | US20040126858 Comprises enzymatic polypeptide for use in identification of modulators for prevention and treatment of free radical damage, inflammatory, metabolic and cancer disorders |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126838 Cell-free, in vitro method of remodeling a (FSH) peptide by deglycosylating and then contacting the truncated glycan with at least one glycosyltransferase and at least one glycosyl donor; improved properties, for its use as a therapeutic agent |
| 07/01/2004 | US20040126828 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 07/01/2004 | US20040126827 Clostridium botulinum neurotoxin for treating spasticity associated with brain ischemia, or traumatic injury of the brain or spinal cord, tension hedache or pain and disorders associated with excessive release of acetylcholine for neuronal tissues |
| 07/01/2004 | US20040126825 Using a compounds ability to decrease integrin activation as a diagnostic tool for the identification of antagonistic modulators of neovascularizaton; antitumor/antiproliferative agents |
| 07/01/2004 | US20040126823 Identifying oncogenic kinase modulators which ca n be used in the prevention and treatment inflammation an d cell proliferative disorders |
| 07/01/2004 | US20040126812 Method for isolating an intestinal cholesterol binding protein |
| 07/01/2004 | US20040126808 Small cell lung cancer associated antigens and uses therefor |
| 07/01/2004 | US20040126805 Nucleic acid and amino acid sequences; diagnosis, treatment and prevention of cancerous, immune and reproductive disorders |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126793 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | US20040126791 Compositions and methods for treating trail-resistant cancer cells |
| 07/01/2004 | US20040126781 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal |
| 07/01/2004 | US20040126771 PRNA chimera |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126449 Topical composition and methods for treatment of aged or environmentally damaged skin |
| 07/01/2004 | US20040126436 Mixture of bicarbonate and enzyme for rermoval of ear wax from ear canal |
| 07/01/2004 | US20040126432 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction |
| 07/01/2004 | US20040126409 comprises cationic proteins/peptides; catheters/stents; contact lenses |
| 07/01/2004 | US20040126397 Neuromuscular disorders |
| 07/01/2004 | US20040126396 Pain therapy; administering neurotoxins |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126380 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 07/01/2004 | US20040126377 Genetic engineered polypeptides; screening, design, genetic mapping; antibodies; psychological disorders, antidepressants |
| 07/01/2004 | US20040126376 Binding to monoclonal antibodies; antitumor agents |
| 07/01/2004 | US20040126375 Controlling gene expression of bone morphogenic proteins; cancer diagnosis |
| 07/01/2004 | US20040126374 Administering immunoglobulins, insulin protein, epitopes and lymphocyte receptor; prevention, suppression, delay diabetes |
| 07/01/2004 | US20040126370 Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| 07/01/2004 | US20040126369 Delivery of peroxide-generating enzymes to the vaginal tract |
| 07/01/2004 | US20040126366 Autism, attention deficit , obsessive complusive disorders , mental retardation |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126362 Anticancer agents; leukemia ; therapy, prevent of metabolism diseases |
| 07/01/2004 | US20040126361 Polymer conjugates of interferon-beta with enhanced biological potency |
| 07/01/2004 | US20040126360 Oral formulations for proteins and polypeptides |
| 07/01/2004 | US20040126359 Modulate lymphocyte activation; cell proliferation; apoptosis; signal transduction |
| 07/01/2004 | US20040126358 Interleukins; enteric coatings; inflammatory bowel disorders;Crohn' sdisease |
| 07/01/2004 | US20040126357 Lectin compositions and methods for modulating an immune response to an antigen |
| 07/01/2004 | CA2808592A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808584A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |